ES434829A1 - Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina. - Google Patents

Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina.

Info

Publication number
ES434829A1
ES434829A1 ES434829A ES434829A ES434829A1 ES 434829 A1 ES434829 A1 ES 434829A1 ES 434829 A ES434829 A ES 434829A ES 434829 A ES434829 A ES 434829A ES 434829 A1 ES434829 A1 ES 434829A1
Authority
ES
Spain
Prior art keywords
piperazine
hydroxypropil
naft
oxi
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES434829A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES434829A1 publication Critical patent/ES434829A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES434829A 1974-02-23 1975-02-18 Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina. Expired ES434829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2408804A DE2408804C2 (de) 1974-02-23 1974-02-23 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten

Publications (1)

Publication Number Publication Date
ES434829A1 true ES434829A1 (es) 1976-12-01

Family

ID=5908286

Family Applications (1)

Application Number Title Priority Date Filing Date
ES434829A Expired ES434829A1 (es) 1974-02-23 1975-02-18 Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina.

Country Status (20)

Country Link
US (1) US3997666A (en, 2012)
JP (1) JPS6029712B2 (en, 2012)
AR (1) AR206339A1 (en, 2012)
AT (1) AT340937B (en, 2012)
BE (1) BE825755A (en, 2012)
CA (1) CA1039282A (en, 2012)
CH (2) CH609342A5 (en, 2012)
DE (1) DE2408804C2 (en, 2012)
DK (1) DK135124C (en, 2012)
ES (1) ES434829A1 (en, 2012)
FI (1) FI59248C (en, 2012)
FR (1) FR2261770B1 (en, 2012)
GB (1) GB1445548A (en, 2012)
IE (1) IE40678B1 (en, 2012)
NL (2) NL175059B (en, 2012)
PL (1) PL92131B1 (en, 2012)
SE (1) SE405601B (en, 2012)
SU (2) SU549085A3 (en, 2012)
YU (2) YU37156B (en, 2012)
ZA (1) ZA751031B (en, 2012)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387971A1 (fr) * 1977-04-19 1978-11-17 Delalande Sa Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
US4882330A (en) * 1986-11-21 1989-11-21 A. H. Robins Company, Incorporated 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
EP0269383A3 (en) * 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
DE3918543A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
WO1998033771A1 (fr) 1997-01-30 1998-08-06 Senju Pharmaceutical Co., Ltd. Derives d'hydroquinone
EP1118322A4 (en) 1998-09-30 2004-10-20 Takeda Chemical Industries Ltd MEDICINES THAT IMPROVE BLADDER DRAINING POWER
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
DE60336485D1 (de) 2002-08-19 2011-05-05 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
KR20050085563A (ko) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
US7923467B2 (en) 2003-05-30 2011-04-12 Ranbaxy Laboratories, Inc. Substituted pyrrole derivatives and their use as HMG-CO inhibitors
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US7618972B2 (en) 2005-03-21 2009-11-17 Pfizer Inc Substituted triazole derivatives as oxytocin antagonists
WO2007017752A1 (en) * 2005-08-10 2007-02-15 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20110039892A1 (en) 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN101671317B (zh) * 2009-10-09 2011-04-27 蚌埠丰原涂山制药有限公司 一种萘哌地尔的制备方法
CN101747293B (zh) * 2009-12-29 2011-12-07 蚌埠丰原涂山制药有限公司 萘哌地尔的制备方法
JP5807423B2 (ja) * 2011-07-21 2015-11-10 大日本印刷株式会社 ナフトピジルの製造方法
CN102816136A (zh) * 2012-09-18 2012-12-12 通化吉通药业有限公司 萘哌地尔制备方法
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US9272980B2 (en) 2014-06-06 2016-03-01 Ktn Biotec, Inc. Anticancer agent
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NL7501877A (nl) 1975-08-26
US3997666A (en) 1976-12-14
CH612958A5 (en, 2012) 1979-08-31
FI59248C (fi) 1981-07-10
YU37156B (en) 1984-08-31
ATA132375A (de) 1977-05-15
AU7826875A (en) 1976-08-19
FR2261770B1 (en, 2012) 1978-08-04
CH609342A5 (en, 2012) 1979-02-28
DK135124C (da) 1977-08-15
YU104481A (en) 1983-04-27
DK58175A (en, 2012) 1975-10-20
DE2408804C2 (de) 1983-09-22
FR2261770A1 (en, 2012) 1975-09-19
YU38275A (en) 1983-04-27
IE40678L (en) 1975-08-23
JPS50121286A (en, 2012) 1975-09-23
JPS6029712B2 (ja) 1985-07-12
CA1039282A (en) 1978-09-26
DK135124B (da) 1977-03-07
AT340937B (de) 1978-01-10
FI59248B (fi) 1981-03-31
GB1445548A (en) 1976-08-11
DE2408804A1 (de) 1975-09-04
ZA751031B (en) 1976-02-25
IE40678B1 (en) 1979-08-01
NL175059B (nl) 1984-04-16
YU37157B (en) 1984-08-31
SU549085A3 (ru) 1977-02-28
BE825755A (fr) 1975-08-20
FI750449A7 (en, 2012) 1975-08-24
PL92131B1 (en, 2012) 1977-03-31
NL175059C (nl)
SE7501911L (en, 2012) 1975-08-25
SU561514A3 (ru) 1977-06-05
AR206339A1 (es) 1976-07-15
SE405601B (sv) 1978-12-18

Similar Documents

Publication Publication Date Title
ES434829A1 (es) Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina.
ES452768A1 (es) Procedimiento para la preparacion de nuevos 2-tetrahidrofur-furil-6, 7-benzomorfanos disustituidos en 5, 9-beta.
ES461631A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-(benzazolilalquil)piperidina.
ES419814A1 (es) Un procedimiento de preparacion de un nuevo derivado amini-co del 1,4-benzodioxano.
ES504206A0 (es) Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5
ES8104264A1 (es) Procedimiento para la preparacion de n- (trimetoxibencil)- n'-fenilpiperazinas
DK156655C (da) Pyridazinoner, fremgangsmaade til fremstilling deraf, anvendelse deraf og medikamenter indeholdende pyridazinoner
ES441591A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
SE8405588D0 (sv) New compounds
DE3788373D1 (de) Disubstituierte Piperazine.
ES268523A1 (es) Procedimiento de preparaciën de los derivados trialcoxilados de la bencil-1-piperacina
ATE57095T1 (de) Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks.
ES413153A1 (es) Un procedimiento para la preparacion de anilino benzotia- zoles.
ES388879A1 (es) Procedimiento para la preparacion de 1-(2-nitrilofenoxi)-2-hidroxi-3-etilaminopropano racemico u opticamente activo.
IE40679B1 (en) 1-(3-(napth-1-yloxy)-propyl)-piperazine derivatives
DK313587A (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ES468586A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
ES8603446A1 (es) Procedimiento para preparar la n-(3-trifluorometilfenil)-n'-propargil-piperazina
KR890002079A (ko) 1-[2-(페닐메틸)페닐]피페라진 및 그의 제조방법
ES479448A1 (es) Procedimiento de preparacion de nuevas piperazinas monosus- tituidas y de sus sales de adicion con acidos convenientes.
AR222149A1 (es) Procedimiento para preparar nuevos derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxipropil)-4-aril piperazina
SE7506729L (sv) Forfarande for framstellning av nya substituerade 1-(2',4',6'-trihydrofenyl)-propandion-(1,2)-foreningar
AR207473A1 (es) Procedimiento para la preparacion de nuevos derivados de 3-metil-3-(3,4-dialcoxi(c1-c1)-bencil)-piperazina de 1-difenilmetil-3-metil-3(3,4-dialcoxi(c1-c4)-bencil)-piperazina y de 1-(p-clorofenil-fenilmetil)-3-metil-3-(3,4-dialcoxi(c1-c4)-bencil)-piperazina
GB962944A (en) N,n-disubstituted piperazine derivatives
ES8603854A1 (es) Procedimiento de preparacion de nuevos derivados benzohi- drilpiperacinos y sus sales de adicion acidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623